Dominique Verhelle is co-founder and CEO of the Brighton-based company NextRNA Therapeutics, which uses long non-coding RNA ...

The heart has long been thought to be controlled solely by the autonomic nervous system, which transmits signals from the ...

For decades, scientists believed the heart was a normal organ controlled entirely by the brain. Now, the picture just got a ...

Choosing a film for a movie night is always a battle. Now imagine if you could pick one that provided a window into some of ...

By Dr. Sushama R. Chaphalkar, PhD. A deep-learning method creates a comprehensive reference atlas of CD8+ T cells, ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

Theratechnologies (THTX) has entered into an agreement with Ionis Pharmaceuticals to license two investigational RNA-targeted ...

Theratechnologies (TSE:TH) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

A unique mutation carried by an 8-year-old girl supported a diagnosis of spinal muscle atrophy with lower extremity ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

Immune checkpoint inhibitors may heighten cardiovascular risks by altering immune interactions in atherosclerotic plaques, ...

Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. | ...